FluoroPharma Medical (FPMI)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Jul 2, 2024 02:09 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
FluoroPharma Medical Inc. [FPMI]
Reports for Purchase
Showing records 1 - 20 ( 24 total )
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
ValuEngine Detailed Valuation Report for FPMI
Provider: ValuEngine, Inc
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Dropping coverage due to discontinuance of research services
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Reiterating Speculative Buy and maintaining (12-month) price target of $1.20 per share
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Reiterating Speculative Buy and maintaining (12-month) price target of $1.20 per share
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Reiterating Speculative Buy and maintaining (12-month) price target of $1.20 per share.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Reiterating Speculative Buy but lowering (12-month) price target
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Company: FluoroPharma Medical Inc.
Industry: Medical - Products
Initiating Speculative Buy with a $1.85 (12-month) price target that is based on a long-term revenue outlook.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J